$4.17
-0.1-2.23%
Last update: 1:12 PM
15 minutes delayed
Monte Rosa Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Monte Rosa Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GLUE | Monte Rosa Therapeutics | -$0.71 | -$0.54 | — | — | $0.00 | $1.35M | — | — | 08/08/2024 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$0.65 | -$0.57 | -$0.53 | 7.02% | $0.00 | $1.40M | $1.06M | -24.00% | 05/09/2024 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$0.63 | -$0.33 | -$0.58 | -75.76% | $0.00 | $15.15M | $0.00 | -100.00% | 03/14/2024 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$0.58 | -$0.72 | -$0.70 | 2.78% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$0.57 | -$0.70 | -$0.71 | -1.43% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$0.51 | -$0.68 | -$0.65 | 4.41% | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$0.11 | — | -$0.63 | — | $0.00 | — | $0.00 | — | 03/16/2023 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$0.43 | — | -$0.58 | — | $0.00 | — | $0.00 | — | 11/10/2022 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$3.63 | — | -$0.57 | — | $0.00 | — | $0.00 | — | 08/11/2022 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$7.18 | — | -$0.51 | — | $0.00 | — | $0.00 | — | 05/11/2022 | Get Alert |
GLUE | Monte Rosa Therapeutics | — | — | -$0.11 | — | $0.00 | — | $0.00 | — | 03/29/2022 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$4.29 | — | -$0.43 | — | $0.00 | — | $0.00 | — | 11/10/2021 | Get Alert |
GLUE | Monte Rosa Therapeutics | -$3.64 | — | -$3.63 | — | $0.00 | — | $0.00 | — | 08/12/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.53 | $-0.57 | 7.02 % |
Dec 2023 | 2024-03-14 | $-0.58 | $-0.33 | -75.8 % |
Sep 2023 | 2023-11-09 | $-0.70 | $-0.72 | 2.78 % |
Jun 2023 | 2023-08-10 | $-0.71 | $-0.70 | -1.43 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $1.06M | $1.40M | -24.0 % |
Dec 2023 | 2024-03-14 | $0 | $15.15M | -100.0 % |
Monte Rosa Therapeutics (GLUE) is scheduled to report earnings on August 8, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.53, which beat the estimate of $-0.57.
The Actual Revenue was $1.1M, which missed the estimate of $1.4M.
Browse earnings estimates, EPS, and revenue on all stocks.